These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2681758)

  • 1. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
    Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
    J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid.
    Faaber P; van den Bersselaar LA; van de Putte LB; van den Berg WB
    Arthritis Rheum; 1989 Dec; 32(12):1521-7. PubMed ID: 2688658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM; van Es LA; Westedt ML; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating immune complexes and anti-IgG antibodies in rheumatoid arthritis].
    Duquesnoy B; Santoro F; Wattre P; Delcambre B
    Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):417-21. PubMed ID: 308254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of circulating immune complexes in rheumatoid arthritis.
    Wattre P; Santoro F; Bout D; Defrance D; Capron A
    Biomedicine; 1976 Sep; 25(7):249-51. PubMed ID: 990384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.